Knockdown of Thrombomodulin Enhances HCC Cell Migration through Increase of ZEB1 and Decrease of E-cadherin Gene Expression

被引：0
|
作者：
Ming-Te Huang
Po-Li Wei
Jun-Jen Liu
Der-Zen Liu
Huang Huey-Chun
Jane An
Cheng-Chia Wu
Chih-Hsiung Wu
Yuan-Soon Ho
Yi-Yuan Yang
Yu-Jia Chang
机构：
[1] Taipei Medical University,Department of Surgery
[2] Taipei Medical University-Shuang Ho Hospital,Department of Surgery
[3] Taipei Medical University,Graduate Institute of Biomedical Technology
[4] Taipei Medical University,Graduate Institute of Biomedical Materials and Engineering
[5] China Medical University,Department of Medical Laboratory Science and Biotechnology, College of Health Care
[6] New York Medical College,Center of Excellence for Cancer Research
[7] Taipei Medical University,Graduate Institute of Clinical Medicine
[8] Taipei Medical University,undefined
来源：
Annals of Surgical Oncology | 2010年 / 17卷
关键词：
Thrombin; Migration Ability; Ethylene Glycol Tetraacetic Acid; Ethylene Glycol Tetraacetic Acid; Snail Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3379 / 3385
页数：6
相关论文
共 50 条
  • [41] ZEB1 overexpression associated with E-cadherin and microRNA-200 downregulation is characteristic of undifferentiated endometrial carcinoma
    Romero-Perez, Laura
    Angeles Lopez-Garcia, M.
    Diaz-Martin, Juan
    Biscuola, Michele
    Angeles Castilla, M.
    Tafe, Laura J.
    Garg, Karuna
    Oliva, Esther
    Matias-Guiu, Xavier
    Soslow, Robert A.
    Palacios, Jose
    MODERN PATHOLOGY, 2013, 26 (11) : 1514 - 1524
  • [42] The Expression of E-Cadherin and Vimentin Correlates with Transcription Factors ZEB1 and ZEB2 and Is Differentially Regulated by TGF-β and IL-13 in Leiomyoma.
    Chaudhri, Amra A.
    Padua, Maria B.
    Luo, Xiaoping
    Bukulmez, Orhan
    Chegini, Nasser
    REPRODUCTIVE SCIENCES, 2010, 17 (03) : 269A - 270A
  • [43] The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
    Park, Sun-Mi
    Gaur, Arti B.
    Lengyel, Ernst
    Peter, Marcus E.
    GENES & DEVELOPMENT, 2008, 22 (07) : 894 - 907
  • [44] Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
    Aghdassi, Ali
    Sendler, Matthias
    Guenther, Annett
    Mayerle, Julia
    Behn, Claas-Olsen
    Heidecke, Claus-Dieter
    Friess, Helmut
    Buechler, Markus
    Evert, Matthias
    Lerch, Markus M.
    Weiss, Frank Ulrich
    GUT, 2012, 61 (03) : 439 - 448
  • [45] Zeb1、CtBP1与E-cadherin在结肠腺癌中的表达及意义
    肖胜军
    贾丽婷
    周辉蓉
    张洁
    华夏医学, 2013, 26 (06) : 1048 - 1051
  • [46] Knockdown of E-cadherin expression promote cervical cancer progression through EGFR signaling pathway
    Han, Gwan Hee
    Yun, Hee
    Kim, Sunghoon
    Cho, Hanbyoul
    Kim, Jae-Hoon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A85 - A86
  • [47] Variable expression of ZEB-1, Bcl-2, and E-cadherin in human hepatocholangio and renal cell carcinomas
    Chahine, Joeffrey J.
    Ko, Kyungmin
    Kallakury, Bhaskar V. S.
    Tuma, Pamela L.
    CANCER RESEARCH, 2020, 80 (16)
  • [48] Activin A promotes ovarian cancer cell migration by suppressing E-cadherin expression
    Yi, Yuyin
    Cheng, Jung-Chien
    Klausen, Christian
    Leung, Peter C. K.
    EXPERIMENTAL CELL RESEARCH, 2019, 382 (2-3)
  • [49] XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression
    Cui, Tiantian
    Srivastava, Amit Kumar
    Han, Chunhua
    Yang, Linlin
    Zhao, Ran
    Zou, Ning
    Qu, Meihua
    Duan, Wenrui
    Zhang, Xiaoli
    Wang, Qi-En
    ONCOTARGET, 2015, 6 (12) : 10060 - 10072
  • [50] Spry1 targeting enhances E-cadherin expression in cutaneous melanoma
    Montico, Barbara
    Giurato, Giorgio
    Guerrieri, Roberto
    Salvati, Annamaria
    Colizzi, Francesca
    Baboci, Lorena
    Sigalotti, Luca
    Covre, Alessia
    Maio, Michele
    Steffan, Agostino
    Nyman, Tuula Anneli
    Weisz, Alessandro
    Mongiat, Maurizio
    Andreuzzi, Eva
    Fratta, Elisabetta
    CANCER RESEARCH, 2024, 84 (06)
12345